Table 3 Hazard ratios (HR) and 95% confidence intervals (CI) for the association between quartiles of the advanced glycation end products (AGEs) and mortality in patients with cirrhosis.

From: Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort study

AGEs

Q1

Q2

Q3

Q4

P trend

No. of deaths

6

11

13

20

0.024

Model 1

ref

2.1

(0.69–6.2)

2.47

(0.85–7.1)

2.64

(0.9–7.5)

0.075

Model 2

ref

2.54

(0.81–8)

2.75

(0.79–9.5)

3.56

(1.1–11.6)

0.040

Model 3

ref

1.24

(0.25–6)

2.76

(1.69–11.1)

3.3

(1.79–13.7)

0.048